Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Leverger

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Haematologica|January 14, 2021
Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burdenThomas Pincez, Helder Fernandes, Thierry Leblanc, et al.
Frontiers in Pediatrics|October 21, 2015
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational CohortNathalie Aladjidi, Helder Fernandes, Thierry Leblanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaC Michel Zwaan, Edward A Kolb, Dirk Reinhardt, et al.
Andrology|July 7, 2023
A 10-year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?Virginie Barraud-Lange, Nicolas Boissel, Anne-Sophie Gille, et al.
Blood Advances|October 15, 2025
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched studyThomas Pincez, Helder Fernandes, Guy Leverger, et al.
Blood|April 4, 2019
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genesJérôme Hadjadj, Nathalie Aladjidi, Helder Fernandes, et al.
British Journal of Haematology|November 14, 2018
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort studySébastien Héritier, Mohamed-Aziz Barkaoui, Jean Miron, et al.
American Journal of Hematology|March 7, 2023
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopeniaThomas Pincez, Helder Fernandes, Marlène Pasquet, et al.
American Journal of Hematology|April 23, 2024
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcomeThomas Pincez, Helder Fernandes, Mony Fahd, et al.
Nature Communications|June 22, 2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cellsLaure Delage, Francesco Carbone, Quentin Riller, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Haematologica|January 14, 2021
Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burdenThomas Pincez, Helder Fernandes, Thierry Leblanc, et al.
Frontiers in Pediatrics|October 21, 2015
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational CohortNathalie Aladjidi, Helder Fernandes, Thierry Leblanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaC Michel Zwaan, Edward A Kolb, Dirk Reinhardt, et al.
Andrology|July 7, 2023
A 10-year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?Virginie Barraud-Lange, Nicolas Boissel, Anne-Sophie Gille, et al.
Blood Advances|October 15, 2025
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched studyThomas Pincez, Helder Fernandes, Guy Leverger, et al.
Blood|April 4, 2019
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genesJérôme Hadjadj, Nathalie Aladjidi, Helder Fernandes, et al.
British Journal of Haematology|November 14, 2018
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort studySébastien Héritier, Mohamed-Aziz Barkaoui, Jean Miron, et al.
American Journal of Hematology|March 7, 2023
Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopeniaThomas Pincez, Helder Fernandes, Marlène Pasquet, et al.
American Journal of Hematology|April 23, 2024
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcomeThomas Pincez, Helder Fernandes, Mony Fahd, et al.
Nature Communications|June 22, 2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cellsLaure Delage, Francesco Carbone, Quentin Riller, et al.
Pageof 20